Universal Beteiligungs und Servicegesellschaft mbH Sells 21,341 Shares of Elevance Health, Inc. $ELV
by Danessa Lincoln · The Markets DailyUniversal Beteiligungs und Servicegesellschaft mbH cut its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 7.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 259,037 shares of the company’s stock after selling 21,341 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Elevance Health were worth $95,623,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently made changes to their positions in ELV. Physician Wealth Advisors Inc. grew its stake in shares of Elevance Health by 331.6% in the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock worth $26,000 after acquiring an additional 63 shares during the period. Activest Wealth Management grew its stake in shares of Elevance Health by 66.7% in the third quarter. Activest Wealth Management now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 34 shares during the period. Rossby Financial LCC grew its stake in shares of Elevance Health by 110.0% in the third quarter. Rossby Financial LCC now owns 84 shares of the company’s stock worth $28,000 after acquiring an additional 44 shares during the period. Motco grew its stake in shares of Elevance Health by 334.8% in the third quarter. Motco now owns 100 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the period. Finally, True Wealth Design LLC grew its stake in shares of Elevance Health by 431.8% in the third quarter. True Wealth Design LLC now owns 117 shares of the company’s stock worth $38,000 after acquiring an additional 95 shares during the period. 89.24% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
ELV has been the subject of a number of research analyst reports. Robert W. Baird reduced their price target on shares of Elevance Health from $340.00 to $317.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Royal Bank Of Canada lowered shares of Elevance Health from an “outperform” rating to a “sector perform” rating and set a $358.00 price target for the company. in a research note on Tuesday, February 3rd. Wolfe Research set a $425.00 target price on shares of Elevance Health and gave the company an “outperform” rating in a research report on Thursday, January 8th. Wells Fargo & Company cut their target price on shares of Elevance Health from $424.00 to $391.00 and set an “overweight” rating for the company in a research report on Friday, January 30th. Finally, Jefferies Financial Group cut their target price on shares of Elevance Health from $395.00 to $391.00 and set a “buy” rating for the company in a research report on Monday. Twelve equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Elevance Health has a consensus rating of “Hold” and an average target price of $383.38.
Read Our Latest Analysis on Elevance Health
Elevance Health Stock Performance
Shares of NYSE ELV opened at $327.87 on Wednesday. The firm has a 50 day moving average of $308.88 and a 200 day moving average of $331.60. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $72.02 billion, a price-to-earnings ratio of 13.05, a price-to-earnings-growth ratio of 1.77 and a beta of 0.49. Elevance Health, Inc. has a 12-month low of $273.71 and a 12-month high of $432.93.
Elevance Health (NYSE:ELV – Get Free Report) last announced its earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.74 by $1.84. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. Elevance Health’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter last year, the business earned $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. On average, research analysts anticipate that Elevance Health, Inc. will post 25.82 earnings per share for the current year.
Elevance Health Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 25th. Shareholders of record on Tuesday, March 10th were given a $1.72 dividend. The ex-dividend date was Tuesday, March 10th. This is an increase from Elevance Health’s previous quarterly dividend of $1.71. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.1%. Elevance Health’s dividend payout ratio (DPR) is currently 27.39%.
About Elevance Health
Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.
Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.
Read More
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).